Trial intelligence / Profile preview

Dronabinol Effect on Sleep in Cannabis Users and Non-Users

NCT03560934Phase 1Completed

Sponsor
Oregon Health & Science University
Start
Sep 2018
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of dronabinol in sleep disorder, sponsored by Oregon Health & Science University. Primary endpoint: Sleep Stages. Started Sep 2018; status: completed.

02

Drugs

dronabinol
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT03560934.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03560934.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call